Molecular Mechanisms of Cell Division and Chromosome Segregation: What Can Go Wrong?
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Nuclei: Function, Transport and Receptors".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 9345
Special Issue Editors
Interests: chromosome biology; genome evolution; heterochromatin; epigenetics; chromatin remodeling; cytokinesis; drosophila
Special Issues, Collections and Topics in MDPI journals
2. Pasteur Institute, Fondazione Cenci-Bolognetti, 00161 Rome, Italy
Interests: epigenetics and chromatin remodeling; mechanisms of mitosis in drosophila melanogaster and human; meiosis and spermiogenesis in drosophila melanogaster; cytokinesis; floating-harbor syndrome and tubulinopathies
Special Issues, Collections and Topics in MDPI journals
2. Pasteur Institute of Italy, Roma, Italy
Interests: cell cycle and cell division in Drosophila melanogaster and humans; protein phosphorylation; protein degradation technologies; Chromatin remodeling; gametogenesis in Drosophila melanogaster; tubulinopathies and ciliopathies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cell division consists of a series of tightly controlled events which lead a cell to segregate its genetic material, equally balanced into two daughter cells. The failure of cell division and the resulting generation of genetic instability (including both numerical and structural chromosomal abnormalities) lead to an unstable state, hence activating tumorigenic transformation. Cancer cells strive to elude the surveillance systems that monitor genome stability, such as those coordinated by the transcriptional regulator p53. Therefore, understanding how genetic stability is transmitted through cell division and how uncorrected mitotic errors can originate genetically unbalanced cells is of primary importance to cancer research.
Thus, this Special Issue entitled ‘Molecular Mechanisms of Cell Division and Chromosome Segregation: What Can Go Wrong?’ will discuss how the deregulation of molecular aspects of cell division can generate an unbalanced distribution of chromosomes and in turn contribute to cancer onset and progression. Both original research and review articles are welcome.
Prof. Dr. Patrizio Dimitri
Dr. Giovanni Messina
Guest Editors
Yuri Prozzillo
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mitosis
- cell division
- genetic instability
- aneuploidy
- lagging chromosomes
- chrosomomes misalignment
- mitotic checkpoint
- microtubules attachment
- kinetochores
- microtubules dynamics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Contribution of AurkA/TPX2 overexpression to chromosomal imbalances and cancer
Authors: Federica Polverino; Anna Mastrangelo; Giulia Guarguaglini
Affiliation: Institute of Molecular Biology and Pathology, CNR
Abstract: The AurkA serine/threonine kinase is a key regulator of cell division controlling mitotic entry, centrosome maturation and chromosome segregation. The microtubule-associated protein TPX2 controls spindle assembly and is the main AurkA regulator, contributing to AurkA activation, localisation and stabilisation. Since their identification AurkA and TPX2 have been described as overexpressed in cancer, with significant correlation with highly proliferative and aneuploid tumours. Despite the frequency of AurkA/TPX2 co-overexpression in cancer, investigation of their involvement in tumorigenesis and cancer therapy resistance mostly arises from studies focusing only on one or the other. Here we review the existing literature and discuss the mitotic phenotypes described under AurkA, TPX2 or AurkA/TPX2 overexpression conditions, to build a picture that may help clarify their oncogenic potential through induction of chromosome instability. We highlight the relevance of the AurkA/TPX2 complex as an oncogenic unit, based on which we discuss results of the most recent strategies under development that aim at disrupting the complex as a promising therapeutic perspective.